Home » Topics » BioWorld Science

BioWorld Science
RSS

EAN 2022: At several scales, connective landscape provides lens for neurology

June 28, 2022

RBM22 inversely correlates with prostate cancer aggressiveness

June 28, 2022

IMPACT Therapeutics synthesizes new NUAK inhibitors

June 28, 2022

Chinese researchers identify new JAK1 inhibitors

June 28, 2022

Chengdu Easton Biopharmaceuticals discloses BET inhibitors

June 28, 2022

Targeting of CD46 allows PET imaging of mesothelioma with [89Zr]DFO-YS5

June 28, 2022

Suzhou Vincentage Pharma patents GLP-1 receptor agonists

June 28, 2022

MagicMed Industries discloses new 5-HT2A receptor agonists

June 28, 2022

LETM1 causes mitochondrial osmotic dysregulation tied to pathology

June 28, 2022

RAC1 variants found to cause a novel developmental syndrome

June 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...